Medicare Enrolled
Dr. Harpaul Gill, MD
Neurology · Cypress, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gill from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gill?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gill
Dr. Harpaul Gill is a neurology specialist in Cypress, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gill performed 3,622 Medicare services across 2,511 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gill received a total of $24,764 from 94 pharmaceutical and/or device companies across 1499 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gill is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 14% volume in TX
$24,764 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,622
Medicare services
Top 14% in TX for neurology
2,511
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~191 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,522 | $90 | $333 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
382 | $78 | $285 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
282 | $297 | $1,130 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
207 | $55 | $226 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
167 | $116 | $509 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
103 | $218 | $978 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
103 | $27 | $261 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
102 | $10 | $40 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
102 | $28 | $112 |
| Auditory brainstem response test A test that measures how the brain responds to sound to help diagnose nervous system disorders. The results are interpreted and reported by a medical professional. |
91 | $67 | $250 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
85 | $86 | $629 |
| Visual evoked potential test A test that measures how quickly electrical signals travel from the eye to the brain in response to visual stimuli. |
76 | $53 | $465 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
73 | $225 | $945 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
63 | $138 | $619 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
56 | $105 | $424 |
| Video EEG monitoring, 12-26 hours A 12 to 26-hour test that records brain wave activity while simultaneously capturing video of the patient's behavior. |
40 | $806 | $4,000 |
| VEEG monitoring, 12-26 hours with review This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report. |
40 | $168 | $838 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
36 | $169 | $738 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
22 | $134 | $449 |
| New patient office visit, complex (60-74 min) | 21 | $144 | $640 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
20 | $200 | $819 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
15 | $104 | $309 |
| Continuous EEG brain wave monitoring A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously. |
14 | $203 | $1,000 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$24,764
Total received (2018-2024)
Avg $3,538/year across 7 years
Top 15% in TX for neurology
94
Companies
1,499
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,538 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$226 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,872
2023
$4,209
2022
$4,778
2021
$3,558
2020
$2,337
2019
$3,086
2018
$2,924
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,693
UCB, Inc.
$1,520
ABBVIE INC.
$1,490
ACADIA Pharmaceuticals Inc
$1,371
Teva Pharmaceuticals USA, Inc.
$1,218
Biogen, Inc.
$1,110
Neurocrine Biosciences, Inc.
$853
Alexion Pharmaceuticals, Inc.
$807
AbbVie Inc.
$789
Abbott Laboratories
$770
Adamas Pharmaceuticals, Inc.
$719
Amneal Pharmaceuticals LLC
$647
SK Life Science, Inc.
$631
Lundbeck LLC
$626
GENZYME CORPORATION
$506
EMD Serono, Inc.
$503
Lilly USA, LLC
$484
Genentech USA, Inc.
$475
Biohaven Pharmaceutical Holding Company Ltd.
$372
Astellas Pharma US Inc
$365
Amgen Inc.
$336
ARGENX US, INC.
$333
Bausch Health US, LLC
$331
Biohaven Pharmaceuticals, Inc.
$304
PFIZER INC.
$287
Otsuka America Pharmaceutical, Inc.
$277
Sunovion Pharmaceuticals Inc.
$270
Octapharma USA, Inc.
$267
Banner Life Sciences, LLC
$250
JAZZ PHARMACEUTICALS INC.
$247
GE Healthcare
$223
Endo Pharmaceuticals Inc.
$221
Allergan, Inc.
$198
Sumitomo Pharma America, Inc.
$190
Acorda Therapeutics, Inc
$189
Corium, LLC
$176
IMPEL PHARMACEUTICALS INC.
$175
Supernus Pharmaceuticals, Inc.
$162
Neurelis, Inc.
$162
AstraZeneca Pharmaceuticals LP
$154
CATALYST PHARMACEUTICALS, INC.
$152
ARBOR PHARMACEUTICALS, INC.
$145
Mallinckrodt Hospital Products Inc.
$141
Eisai Inc.
$140
Currax Pharmaceuticals LLC
$126
Avanir Pharmaceuticals, Inc.
$121
Avion Pharmaceuticals
$112
Mallinckrodt LLC
$109
Arbor Pharmaceuticals, Inc.
$102
Grifols USA, LLC
$100
Upsher-Smith Laboratories LLC
$92
Vertical Pharmaceuticals, LLC
$86
Celgene Corporation
$84
Azurity Pharmaceuticals, Inc.
$84
AQUESTIVE THERAPEUTICS, INC.
$77
GE HEALTHCARE
$72
Almatica Pharma LLC
$62
Promius Pharma LLC
$59
Impax Laboratories, Inc.
$58
E.R. Squibb & Sons, L.L.C.
$57
Medtronic USA, Inc.
$55
MITSUBISHI TANABE PHARMA AMERICA, INC.
$53
US WorldMeds, LLC
$50
Boston Scientific Corporation
$49
Collegium Pharmaceutical, Inc.
$44
AbbVie, Inc.
$43
Aprecia Pharmaceuticals, LLC
$41
EISAI INC.
$41
Mallinckrodt Enterprises LLC
$40
GRT US Holding, Inc.
$38
Allergan Inc.
$37
Kyowa Kirin, Inc.
$36
ANI Pharmaceuticals, Inc.
$35
Catalyst Pharmaceuticals, Inc.
$35
InSightec,Inc
$35
Takeda Pharmaceuticals U.S.A., Inc.
$35
BANNER LIFE SCIENCES, LLC
$33
Scilex Pharmaceuticals Inc.
$32
Janssen Pharmaceuticals, Inc
$29
ASSERTIO THERAPEUTICS, Inc.
$28
Bayer Healthcare Pharmaceuticals Inc.
$27
Janssen Biotech, Inc.
$25
SANOFI-AVENTIS U.S. LLC
$25
Axsome Therapeutics, Inc.
$24
Xeris Pharmaceuticals, Inc.
$24
Medtronic, Inc.
$22
Gilead Sciences, Inc.
$22
LivaNova USA, Inc.
$22
Bayer HealthCare Pharmaceuticals Inc.
$21
Marinus Pharmaceuticals, Inc.
$20
Shire North American Group Inc
$18
GE HealthCare
$18
SCILEX PHARMACEUTICALS INC.
$16
Horizon Therapeutics plc
$14
Top 3 companies account for 19.0% of total payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ACTIVA PC · ADLARITY · ADUHELM · AFINITOR · AGAMREE · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Activase · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BRILINTA · Betaseron · Briviact · COMIRNATY · CONTRAVE · COPAXONE · CREXONT · Cambia · DIVIGEL · DUOPA · Dayvigo · Dhivy · Duopa · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · ETERNA · Edarbyclor · Enspryng · Evrysdi · Exablate · FARXIGA · FIRDAPSE · Fintepla · Fycompa · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gralise · HORIZANT · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LORZONE · LYRICA · Leqembi · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NASCOBAL · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONZETRA XSAIL · OSMOLEX ER · Ocrevus · Ongentys · PANZYGA · PLEGRIDY · PURIFIED CORTROPHIN GEL · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · RADICAVA · REXULTI · RYBREVANT · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SUNOSI · SYMPAZAN · Soliris · Spritam · Stivarga · Sunosi · TECFIDERA · TEPEZZA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trodelvy · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · XCOPRI · XIIDRA · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTALMY · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $684 per 100 Medicare services performed
Geographic Context
Neurologists within 10 mi
132
Per 100K population
2.8
County median income
$73,104
Nearest hospital
LONE STAR BEHAVIORAL HEALTH CYPRESS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gill is a clinical cardiology specialist, with above-average Medicare volume (top 14% in TX), with low-engagement industry engagement in the top 15% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gill experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gill performed 1,522 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gill receive payments from pharmaceutical companies?
Yes. Dr. Gill received a total of $24,764 from 94 companies across 1,499 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gill's costs compare to other neurologists in Cypress?
Dr. Gill's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gill) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Cypress
Browse neurologists in Cypress ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology